Clinical trials
Phase 1/2 Fabry Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4D Molecular Therapeutics | 2 |
| Protalix | 2 |
| Spur Therapeutics | 2 |
| AVROBIO | 1 |
| Guangzhou Jiayin Biotech Ltd | 1 |
| Resverlogix Corp | 1 |
| Sangamo Therapeutics | 1 |
| UniQure Biopharma B.V. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fabry Disease | 11 |
| Lysosomal Storage Diseases | 6 |
| Cardiovascular Diseases | 3 |
| Central Nervous System Diseases | 2 |
| Cerebral Small Vessel Diseases | 2 |
| Cerebrovascular Disorders | 2 |
| Genetic Diseases, Inborn | 2 |
| Lipid Metabolism Disorders | 2 |
| Lipidoses | 2 |
| Metabolic Diseases | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.